According to estimates, hospitals mark up the prices of drugs for patients with private insurance by an average of 140% to 280%. (Photo: Rido/Shutterstock.com)

The cost of cancer care is a major concern for patients, payers and policymakers – and it continues to grow.

U.S. spending on all cancer therapies increased from $39.1 billion in 2015 to $67.5 billion in 2019. Some novel anticancer therapies are priced at more than $100,000 per year. As a result, some patients incur debt, reduce spending on other necessities or forgo recommended treatments altogether.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2022 ALM Global, LLC. All Rights Reserved.